$AME

US$277 - That's What Analysts Think AMETEK, Inc. (NYSE:AME) Is Worth After These Results

AMETEK (NYSE:AME) shares rose 4.9% to close at $254 after quarterly results. Revenues were $2.0b, 4.5% above expectations, and EPS was $1.77, in line with forecasts. Analysts now project 2026 revenue of $8.19b and EPS of $7.36, up from $8.02b and $7.24. Consensus price target increased 5.3% to $277.

Original reporting
Published Aug 8, 2026, 12:53 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 1:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
US$277 - That's What Analysts Think AMETEK, Inc. (NYSE:AME) Is Worth After These Results — source image
Decision brief

The 30-second read

$AMEBullishLow
01

Why it matters

It frames the move as a modest improvement in 2026 revenue expectations and a higher consensus price target, while emphasizing that EPS sentiment is largely unchanged and growth is expected to be slower than industry peers.

02

Market read

Traders get a quick read on how sell-side consensus shifted after the earnings print, but the changes described are not large enough to imply a major new catalyst.

03

What to watch

The piece does not detail segment margin, backlog, guidance for 2027, or balance-sheet risk, which could dominate the stock’s next move despite the higher price target.

Relevance 4/10Novelty 3/10Timing: post-earnings, same-week analyst forecast update

Background

The article summarizes AMETEK’s quarterly results and the subsequent consensus forecast changes from analysts.

Company-level read

Ticker impact

$AMEBullishMedium confidence
Context

AMETEK shares rose 4.9% after quarterly results, with revenues 4.5% ahead of expectations and EPS $1.77 in line.

Expected impact

Near-term bias modestly positive, but magnitude likely limited because EPS view is unchanged and growth is still below industry.

Evidence & confidence

The article cites a small revenue forecast upgrade and a higher consensus price target, while stating EPS is in line and sentiment is largely reconfirmed.

Market effects

Signals steady demand and execution for industrial instrumentation/electromechanical peers, but with slower-than-industry growth expectations.

No specific regional spillover beyond US industrials sentiment.

No explicit global macro or international catalyst beyond company-specific results and consensus updates.

Counterpoint

The upgrade is incremental: EPS expectations are unchanged and revenue growth is still forecast to lag industry, limiting upside follow-through.

Key entities

  • AMETEK, Inc.

    US-listed industrial company whose quarterly results and analyst forecast updates are discussed.

Related articles

$AMEHighAI 9/10

AMETEK Completes Acquisition of Indicor Instrumentation

AMETEK, Inc. (NYSE: AME) completed its $5.0 billion acquisition of Indicor Instrumentation. The deal adds businesses that design and manufacture mission-critical industrial and scientific solutions. Indicor Instrumentation is expected to contribute $350 million to AMETEK's 2026 sales and be modestly accretive to earnings. The acquisition aligns with AMETEK's growth strategies and market focus.

$AMEHighAI 9/10

AMETEK Raises 2026 Outlook After Earnings Climb 17%

AMETEK (NYSE: AME) raised its 2026 outlook after Q2 results. Second-quarter adjusted earnings rose 17% to $2.09 per diluted share, with sales up 15% to $2.04 billion and orders up 28%. AMETEK now expects 2026 adjusted earnings of $8.20 to $8.30 per share and sales up about 10% from 2025.

$AMEHighAI 9/10

AMETEK (AME) Q2 2026 Earnings Call Transcript

AMETEK (AME) reported Q2 2026 net sales of $2.04B, up 15% year over year, with 10% organic growth. Adjusted EPS was $2.09, up 17%, above guidance of $1.96 to $2.00. Total orders were $2.3B, up 28%, backlog $4.11B. Full-year sales guidance rose about 10% and adjusted EPS to $8.20-$8.30.

$AMEMed

Segment Demand and Strategic Acquisitions Propel Growth

AMETEK (NYSE: AME) reported Q2 CY2026 revenue of $2.04 billion, up 15% year over year, beating Wall Street expectations. Non-GAAP EPS was $2.09, 4.8% above consensus. Management cited organic growth, rising orders and backlog of $4.11 billion, and contributions from acquisitions. Full-year guidance was raised, supported by AI, defense, and power grid demand.

$AMEMedAI 8/10

AMETEK, Inc. Q2 2026 Earnings Call Summary

AMETEK reported Q2 2026 momentum driven by multi-year infrastructure build-outs for AI, semiconductors, and power. Organic sales growth accelerated, with a record $4.11B backlog and about 80% expected to ship in 12 months. Core EMG margins rose 290 bps. Full-year 2026 organic sales guidance was raised to mid-to-high single digits; Indicor Instrumentation acquisition of $5B expected to close in H2 with 10% to 12% synergies.

$AMEHigh

AMETEK INC/ (AME): Results of Operations and Financial Condition

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ametek8kexhibit99108042026.htm EX-99.1 Document Exhibit 99.1 AMETEK Announces Record Second Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Aug 4, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the second quarter ended June 30,